Physician profile
Tara L Reyes
NPI 1023881927
$507.11
in general payments reported to CMS, 2019-2025
9 companies · $322 in 2025
The $322 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $185 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $231.32 | 2024-2025 | Wegovy |
| Evoke Pharma, INC. | $101.25 | 2025 | |
| Ucb, INC. | $33.52 | 2025 | Nayzilam |
| Jazz Pharmaceuticals INC. | $32.96 | 2024 | |
| Sk Life Science, INC. | $25.64 | 2024 | Xcopri |
| Acadia Pharmaceuticals INC | $23.81 | 2025 | Daybue |
| Sun Pharmaceutical Industries INC. | $21.98 | 2025 | |
| Exact Sciences Corporation | $18.68 | 2024 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $17.95 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Reyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.